Lori McNeill - Sep 25, 2022 Form 3 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, Attorney-in-Fact
Stock symbol
SONN
Transactions as of
Sep 25, 2022
Transactions value $
$0
Form type
3
Date filed
10/4/2022, 04:30 PM
Next filing
Dec 22, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24- Power of Attorney